Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. - Wikidata - wikimedia - TriplyDB

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.

http://www.wikidata.org/entity/Q48291216

about

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis Understanding and treating triple-negative breast cancer Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells Brain metastasis in human epidermal growth factor receptor 2-positive breast cancer: from biology to treatment Molecular and Genetic Predictors of Breast-to-Brain Metastasis: Review and Case Presentation Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer Molecular interactions in the development of brain metastases PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer Magnetic resonance-guided focused ultrasound surgery: Part 2: A review of current and future applications.Progress and problems in the application of focused ultrasound for blood-brain barrier disruption.Ultrasound for drug and gene delivery to the brain.Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption.Advanced magnetic resonance imaging biomarkers of cerebral metastases.Brain metastasis in patients with metastatic breast cancer in the real world: a single-institution, retrospective review of 12-year follow-up.Carcinomatous meningitis due to gastric adenocarcinoma: A rare presentation of relapse.EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth.Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials.Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada - Clinical Trials Group (NCIC-CTG).Role of KCNMA1 gene in breast cancer invasion and metastasis to brain.Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review RNA interference and nonviral targeted gene therapy of experimental brain cancer Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective study.Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA.Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases.Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study.Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases--the UK experience.Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies.DNA double-strand break repair genes and oxidative damage in brain metastasis of breast cancer.Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer: epidemiological and clinical data from a population-based cancer registry study.Profound prevention of experimental brain metastases of breast cancer by temozolomide in an MGMT-dependent manner.Brain metastases from breast cancer: proposition of new prognostic score including molecular subtypes and treatment.Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of death Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer.Clinical Experience with Lapatinib in Patients with ErbB2-Overexpressing Metastatic Breast Cancer Antibodies and Tyrosine Kinase Inhibitors in Breast Cancer Therapies.MiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN.

P2860

Q24608039-20324D8D-BA8D-4985-BB20-AEB71883D3D2 Q24620957-6226EA20-0B7A-4BE3-957B-CF18738FC356 Q24651212-5297E5F1-9BBE-48F8-875C-FDA38C09D28D Q26748850-D33A2EDF-BCF3-4ADC-AB4E-0DCDBE06F2E1 Q26751008-995B3A50-D02F-434C-8EC7-6102B2202E3D Q26800626-96E825D2-CEF3-4DCF-8CB8-059EFF75DC9E Q26824799-91D05CF0-CFB7-4B1A-86C4-BB6C0BC29DCA Q26865865-A86BE248-BE2D-4D66-B1B5-91FAF2EA2998 Q27006181-9CA10CEC-D3C2-485D-9EC0-12B3253DF8DF Q30411823-F65B89C2-1C3F-4022-B62C-7AFBFBB5C764 Q30487878-137B3EEA-840A-488B-8875-5B66E53357DB Q30488675-7A6A48BE-AB52-4EC1-A7B3-B42E3DA91F9E Q30500905-FFACD0FE-7D02-466D-9842-7E4C488F329B Q30560150-57DE4BB0-9398-4C60-AD22-DECF0A46DB9B Q31154571-BEE22E95-EBB6-45FB-9CEF-08962DC8CD4C Q33165072-604CA7A7-BB5F-48A6-AA8D-AFF2B241D583 Q33257109-509F6BD9-416F-4F60-A1A7-0AC142AD6F43 Q33279460-1A80F565-66FC-45A9-8BA7-1F6080D04AEA Q33280035-A86B2071-A1A9-4395-8CB2-3E5A0EEF3DF0 Q33293618-B2306A90-335F-44AE-8328-8396BB49A3CF Q33370672-ADEFBA93-4CEB-43CE-97AD-A7ACAAE301FE Q33488361-BD064293-EC7C-4100-83C9-A023D8D13383 Q33561966-01638209-FF3D-4602-ACFF-B071CBDE4406 Q33569727-58D47BBA-3BF1-4DD2-9BC4-903E359DDC7A Q33595274-3FF1013A-CF56-46FF-B8DA-4A4361FB685C Q33683140-FDAA646C-0109-41DA-8C85-80D8460A7B6F Q33715354-25EF2243-5EBA-4D61-81BF-4A7BD44F19B7 Q33739253-40DCA21F-D102-4C70-9540-2028322E7B76 Q33747400-C7A7F6DC-691A-47B0-8270-54760976B5B4 Q33805406-86D720A4-5C8B-46A8-9548-B8C624A16B75 Q33815545-A8C3B37F-7B8B-4E6D-92BB-F40773C21EDC Q33874796-6B6D31E0-A2B5-4906-9B4D-89DF3AFCE34C Q33878643-D77C37B4-219A-42E6-9887-4B59D4225B89 Q33909294-DEFB6332-B066-4C44-8D94-1809F386E0FA Q33953465-1A7BFA5D-D586-479B-A2B8-4B03BF986581 Q34022312-CE747380-3D08-4209-AE44-92DBE1933E5E Q34058510-04691F39-4038-4A41-A1C6-91D7EA798588 Q34095748-50622A9E-1CD2-415F-8101-DF67CEB78716 Q34140167-0AF90FD1-1A32-4AD0-8CAC-0155CFCBFD2D Q34179919-2AE490A8-2DDB-4B50-9BE8-79CC9FAD55DF

P2860

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.

http://www.wikidata.org/entity/Q48291216

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Central nervous system metasta ...... r metastatic breast carcinoma.

@en

Central nervous system metasta ...... r metastatic breast carcinoma.

@nl

type

label

Central nervous system metasta ...... r metastatic breast carcinoma.

@en

Central nervous system metasta ...... r metastatic breast carcinoma.

@nl

prefLabel

Central nervous system metasta ...... r metastatic breast carcinoma.

@en

Central nervous system metasta ...... r metastatic breast carcinoma.

@nl

P1433

Q48291216-E8DE741D-079A-4ADC-801B-D6542BFF3206

P1476

Q48291216-B632BA42-0C84-4D07-B919-54895AE8341D

P2093

Q48291216-1BEE1D9C-9CE3-4FAB-8C27-6ED6F4616446

Q48291216-1C88C937-1BF6-4344-907B-CB11482D084B

Q48291216-780D54A5-EC04-4CCF-BCF5-ED0F3CCBFEAD

Q48291216-8BDEBE13-722B-4035-BCF6-435353BD7C7A

Q48291216-B128D20A-3DF8-45C4-AA8D-679E468E8F5D

Q48291216-CB6E415F-ECF5-466B-BA32-BD30B5BEFE6C

Q48291216-F36EC013-6721-4F3D-9482-C98063298871

Q48291216-F481DDF5-ABDD-4B0D-8D68-E98842671B50

P304

Q48291216-C12F65BF-9B4F-4773-A010-CAB335979022

P31

Q48291216-9085B6C1-A686-485A-B176-0C26FD6CE6AE

P356

Q48291216-527154C0-7CE0-4C7D-83FE-A663548DDE3B

P407

Q48291216-2046F606-3EED-46D4-9A8A-92E71410C43A

P433

Q48291216-0A88AADA-BF03-4C6B-ABE5-D847AC77ABB0

P478

Q48291216-17F89DDD-1CAA-4000-BEDD-F58AE88296B6

P50

Q48291216-045A3F28-208D-42C9-AA93-7538063D91C8

Q48291216-9FFDCDED-4B4C-4003-8159-B9861420CD40

P577

Q48291216-1C8DC019-DCEB-44C8-89AA-724644FC5210

P5875

Q48291216-2B40D902-8455-45D8-8936-028AF38A2D19

P698

Q48291216-F0874CE7-E3BD-436E-BC14-EB29160B69F9

P356

P1433

P1476

Central nervous system metasta ...... r metastatic breast carcinoma.

@en

P2093

Craig Bunnell

http://www.w3.org/2001/XMLSchema#string

Eric Winer

http://www.w3.org/2001/XMLSchema#string

Harold J Burstein

http://www.w3.org/2001/XMLSchema#string

Irene Kuter

http://www.w3.org/2001/XMLSchema#string

Jerry Younger

http://www.w3.org/2001/XMLSchema#string

Johanna C Bendell

http://www.w3.org/2001/XMLSchema#string

Lyndsay Harris

http://www.w3.org/2001/XMLSchema#string

Rebecca Gelman

http://www.w3.org/2001/XMLSchema#string

P304

2972-2977

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.11436

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P50

Montserrat Rué

Susan M Domchek

P577

2003-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10728215

http://www.w3.org/2001/XMLSchema#string

P698

12784331

http://www.w3.org/2001/XMLSchema#string